Association Between Earlier Introduction of Peanut and Prevalence of Peanut Allergy in Infants in Australia.


Journal

JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160

Informations de publication

Date de publication:
05 07 2022
Historique:
entrez: 5 7 2022
pubmed: 6 7 2022
medline: 7 7 2022
Statut: ppublish

Résumé

Randomized clinical trials showed that earlier peanut introduction can prevent peanut allergy in select high-risk populations. This led to changes in infant feeding guidelines in 2016 to recommend early peanut introduction for all infants to reduce the risk of peanut allergy. To measure the change in population prevalence of peanut allergy in infants after the introduction of these new guidelines and evaluate the association between early peanut introduction and peanut allergy. Two population-based cross-sectional samples of infants aged 12 months were recruited 10 years apart using the same sampling frame and methods to allow comparison of changes over time. Infants were recruited from immunization centers around Melbourne, Australia. Infants attending their 12-month immunization visit were eligible to participate (eligible age range, 11-15 months), regardless of history of peanut exposure or allergy history. Questionnaires collected data on demographics, food allergy risk factors, peanut introduction, and reactions. All infants underwent skin prick tests to peanut and those with positive results underwent oral food challenges. Prevalence estimates were standardized to account for changes in population demographics over time. This study included 7209 infants (1933 in 2018-2019 and 5276 in 2007-2011). Of the participants in the older vs more recent cohort, 51.8% vs 50.8% were male; median (IQR) ages were 12.5 (12.2-13.0) months vs 12.4 (12.2-12.9) months. There was an increase in infants of East Asian ancestry over time (16.5% in 2018-2019 vs 10.5% in 2007-2011), which is a food allergy risk factor. After standardizing for infant ancestry and other demographics changes, peanut allergy prevalence was 2.6% (95% CI, 1.8%-3.4%) in 2018-2019, compared with 3.1% in 2007-2011 (difference, -0.5% [95% CI, -1.4% to 0.4%]; P = .26). Earlier age of peanut introduction was significantly associated with a lower risk of peanut allergy among infants of Australian ancestry in 2018-2019 (age 12 months compared with age 6 months or younger: adjusted odds ratio, 0.08 [05% CI, 0.02-0.36]; age 12 months compared with 7 to less than 10 months: adjusted odds ratio, 0.09 [95% CI, 0.02-0.53]), but not significant among infants of East Asian ancestry (P for interaction = .002). In cross-sectional analyses, introduction of a guideline recommending early peanut introduction in Australia was not associated with a statistically significant lower or higher prevalence of peanut allergy across the population.

Identifiants

pubmed: 35788795
pii: 2793827
doi: 10.1001/jama.2022.9224
pmc: PMC9257582
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

48-56

Commentaires et corrections

Type : CommentIn

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):466-475.e1
pubmed: 28734861
Allergy. 2012 Nov;67(11):1415-22
pubmed: 22957661
Pediatr Dermatol. 2016 Jan-Feb;33(1):103-6
pubmed: 26354148
Expert Rev Mol Med. 2014 Mar 07;16:e4
pubmed: 24602341
Nat Commun. 2020 Mar 24;11(1):1452
pubmed: 32210229
Int J Epidemiol. 2015 Aug;44(4):1161-71
pubmed: 25613427
JAMA. 2016 Sep 20;316(11):1181-1192
pubmed: 27654604
J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):440-448.e2
pubmed: 29248387
N Engl J Med. 2016 May 5;374(18):1733-43
pubmed: 26943128
J Allergy Clin Immunol. 2021 May;147(5):1823-1829.e11
pubmed: 33810856
BMJ Open. 2015 Dec 16;5(12):e009377
pubmed: 26674499
Allergy. 2021 Oct;76(10):3171-3182
pubmed: 33751595
J Allergy Clin Immunol. 2017 Jan;139(1):29-44
pubmed: 28065278
Pediatr Allergy Immunol. 2018 Feb;29(1):18-27
pubmed: 29068090
Clin Exp Allergy. 2016 Jan;46(1):42-7
pubmed: 26661569
J Allergy Clin Immunol. 2015 May;135(5):1257-66.e1-2
pubmed: 25725989
J Allergy Clin Immunol. 2019 Nov;144(5):1327-1335.e5
pubmed: 31401287
J Allergy Clin Immunol. 2016 Oct;138(4):1131-1141.e2
pubmed: 27260320
Clin Exp Allergy. 2009 Jul;39(7):991-8
pubmed: 19302247
Int J Epidemiol. 2016 Dec 1;45(6):1887-1894
pubmed: 28089956
J Pediatr Gastroenterol Nutr. 2017 Jan;64(1):119-132
pubmed: 28027215
J Paediatr Child Health. 2017 Sep;53(9):870-875
pubmed: 28603870
J Allergy Clin Immunol. 2014 Feb;133(2):476-84
pubmed: 24388636
Int J Epidemiol. 2018 Feb 1;47(1):217-225
pubmed: 29025097
N Engl J Med. 2015 Feb 26;372(9):803-13
pubmed: 25705822
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Allergy. 2014 Dec;69(12):1639-47
pubmed: 25041549

Auteurs

Victoria X Soriano (VX)

Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia.
Centre for Food and Allergy Research (CFAR), Murdoch Children's Research Institute, Parkville, Victoria, Australia.

Rachel L Peters (RL)

Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia.

Margarita Moreno-Betancur (M)

Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia.

Anne-Louise Ponsonby (AL)

Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia.
Centre for Food and Allergy Research (CFAR), Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
School of Population and Global Health, University of Melbourne, Parkville, Victoria, Australia.

Grace Gell (G)

Murdoch Children's Research Institute, Parkville, Victoria, Australia.

Alexsandria Odoi (A)

Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia.

Kirsten P Perrett (KP)

Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia.
Centre for Food and Allergy Research (CFAR), Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Allergy and Immunology, Royal Children's Hospital, Parkville, Victoria, Australia.

Mimi L K Tang (MLK)

Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia.
Centre for Food and Allergy Research (CFAR), Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Allergy and Immunology, Royal Children's Hospital, Parkville, Victoria, Australia.

Lyle C Gurrin (LC)

Centre for Food and Allergy Research (CFAR), Murdoch Children's Research Institute, Parkville, Victoria, Australia.
School of Population and Global Health, University of Melbourne, Parkville, Victoria, Australia.

Katrina J Allen (KJ)

Federal Parliament of Australia.

Shyamali C Dharmage (SC)

Centre for Food and Allergy Research (CFAR), Murdoch Children's Research Institute, Parkville, Victoria, Australia.
School of Population and Global Health, University of Melbourne, Parkville, Victoria, Australia.

Jennifer J Koplin (JJ)

Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia.
Centre for Food and Allergy Research (CFAR), Murdoch Children's Research Institute, Parkville, Victoria, Australia.
School of Population and Global Health, University of Melbourne, Parkville, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH